Beyond the Pain Scale: Nine Essential Lessons from the Chronic Pain Community on November 1, 2026 Posted by
The Weight of Exclusion: Why Current Obesity Thresholds Fail Asian Patients on October 31, 2026 Posted by
Navigating Life After an Ehlers-Danlos Syndrome Diagnosis: A Comprehensive Guide to Management and Empowerment on October 31, 2026 Posted by
The Viscous Trap: How Brain Cancer Exploits Physical Resistance to Accelerate Invasion on October 31, 2026 Posted by
Groundbreaking Partnership: UPnRIDE and Kessler Foundation Collaborate to Redefine Upright Mobility for People with Disabilities on October 31, 2026 Posted by
The Vanguard of Gen Z Advocacy: Active Minds Announces 2026-2027 Student Advisory Committee Cohort on October 31, 2026 Posted by
Beyond the Pain Scale: Nine Essential Lessons from the Chronic Pain Community on November 1, 2026 Posted by
The Weight of Exclusion: Why Current Obesity Thresholds Fail Asian Patients on October 31, 2026 Posted by
Navigating Life After an Ehlers-Danlos Syndrome Diagnosis: A Comprehensive Guide to Management and Empowerment on October 31, 2026 Posted by
Posted in Medical Innovations High-Stakes Battle: Amgen Fights to Save Vasculitis Drug Tavneos from FDA Withdrawal on July 26, 2026
Posted in Digital Health Tools A New Era in Thyroid Eye Disease: FDA Approves Viridian’s Lumvoa, Challenging the Amgen Monopoly on June 29, 2026
Posted in Digital Health Tools Regulatory Crisis Deepens: Amgen’s Tavneos Faces Global Withdrawal Amid Data Integrity Concerns on June 27, 2026
Posted in Digital Health Tools The Battle for Tavneos: Amgen Challenges FDA’s Bid to Pull Rare Disease Drug from Market on June 14, 2026
Posted in Medical Innovations Industry Pulse: FDA Leadership Overhaul, Amgen Safety Crisis, and Emerging Breakthroughs in Obesity and Oncology on May 19, 2026 rifanmuazin
